Arizona 2024 2024 Regular Session

Arizona Senate Bill SB1191 Comm Sub / Analysis

Filed 03/05/2024

                    Assigned to HHS & APPROP 	AS PASSED BY COW 
 
 
 
 
ARIZONA STATE SENATE 
Fifty-Sixth Legislature, Second Regular Session 
 
REVISED 
FACT SHEET FOR S.B. 1191 
 
developmental disabilities; Prader-Willi syndrome 
Purpose 
Expands the definition of developmental disability to include a severe, chronic disability 
that is attributable to Prader-Willi syndrome for the purpose of receiving services through the 
Department of Economic Security (DES) Division of Developmental Disabilities (DDD).  
Background 
Prader-Willi syndrome is the most common of the genetic disorders that cause  
life-threatening obesity in children. Prader-Willi syndrome is caused by genetic changes on an 
unstable region of chromosome 15 that affects the regulation of gene expression, or how genes 
turn on and off. After infancy, symptoms of Prader-Willi syndrome include uncontrolled eating 
and delays in reaching physical activity milestones, such as standing and walking (NIH). 
A developmental disability is either a strongly demonstrated potential that a child who is 
under six years of age has or will develop a developmental disability, as determined by a prescribed 
test or by other appropriate tests, or a severe, chronic disability that: 1) is attributable to a cognitive 
disability, cerebral palsy, epilepsy, Down syndrome or autism; 2) is manifested before the age of 
18; 3) is likely to continue indefinitely; 4) reflects the need for a combination and sequence of 
individually planned or coordinated special, interdisciplinary or generic care, treatment or other 
services that are of lifelong or extended duration; and 5) results in substantial functional limitations 
in three or more areas of major life activity. Areas of major life activity include: 1) self-care;  
2) receptive and expressive language; 3) learning; 4) mobility; 5) self-direction; 6) capacity for 
independent living; and 7) economic self-sufficiency (A.R.S. § 36-551).  
The Director of DES is responsible for developing and annually revising a statewide plan 
and initiating statewide programs and services for persons with developmental disabilities. 
Services include child, adult, residential and resource services. An Arizona resident with a 
developmental disability, supported by medical and psychological documentation, is eligible to 
apply for developmental disabilities programs, services and facilities operated, licensed and 
supervised by DES (A.R.S. §§ 36-554 and 36-559). 
DDD is the division of DES that empowers individuals with developmental disabilities to 
lead self-directed, healthy and meaningful lives. DDD provides support and services for eligible 
Arizonans diagnosed with one of the following developmental disabilities: 1) autism; 2) cerebral 
palsy; 3) epilepsy; 4) cognitive or intellectual disability; and 5) Down syndrome. Children under 
the age of six who are at risk of having a developmental disability may also qualify. DDD serves 
more than 40,000 people with developmental disabilities and their families throughout Arizona 
each year (DDD).  FACT SHEET – Revised  
S.B. 1191 
Page 2 
 
 
The Joint Legislative Budget Committee fiscal note on S.B. 1191 estimates that the bill 
would increase enrollment in the DDD program by 183 individuals annually and that each enrollee 
would have service costs of $74,100 annually. As a result, the bill would increase DDD costs by 
$4.67 million from the General Fund annually (JLBC). 
Provisions 
1. Expands the definition of developmental disability to include a severe, chronic disability that 
is attributable to a pathogenic genetic mutation associated with neurodevelopmental 
disabilities, including Prader-Willi syndrome. 
2. Defines Prader-Willi syndrome as a genetic disorder that is characterized by short stature, 
cognitive impairment, hypotonia, abnormally small hands and feet, hypogonadism and 
uncontrolled appetite leading to extreme obesity. 
3. Makes conforming changes. 
4. Becomes effective on the general effective date. 
Revised 
• Updates the fiscal impact statement. 
Senate Action  
HHS 1/30/24 DP 7-0-0 
APPROP 2/6/24 DP 7-2-1 
Prepared by Senate Research 
March 5, 2024 
MM/KS/slp